|
|
Strategic Analysis of World DNA Microarray MarketsPublished by: Frost & Sullivan Published: Mar. 1, 2004 Table of Contents1 | STRATEGIC ANALYSIS OF WORLD DNA MICROARRAY MARKETS Introduction 1. Introduction 2. Disclaimer 3. Certification 4. Research Scope and Methodology Overview and Scope 1. Outline Slide 2. Summary of Findings 3. Market Maturation Process 4. Customer Priorities 5. Competitive Framework 6. Potential Threats 7. Market Potential Strategic Analysis 1. Outline Slide 2. Market Segmentation 3. Market Drivers 4. Market Restraints 5. Industry Challenges 6. Challenges & Strategies I 7. Challenges & Strategies II 8. Challenges & Strategies III 9. Challenges & Strategies IV 10. Market Trends 11. Technology Trends Total Market 1. Outline Slide 2. Key Market Engineering Measurements 3. Executive Quote I 4. Total Market Revenue Forecast 5. Revenue Analysis 6. Total Market Revenue Forecast by Segment 7. Geographical Breakdown 8. Understanding Growth Opportunities 9. Market Positioning Commercial Segment 1. Outline Slide 2. Key Market Engineering Measurements 3. Executive Quote II 4. Commercial Market Revenue Forecast 5. Revenue Analysis 6. Commercial Market Revenue Forecast by Segment 7. Revenue Forecast - Commercial Instruments 8. Revenue Forecast - Commercial Reagents 9. Revenue Forecast - Commercial Pre-printed Microarrays 10. Forecast Assumptions 11. Market Share - Commercial Microarray Products 12. Understanding Growth Opportunities 13. Revenue Forecast - Molecular Diagnostics Scenario Self-printed Segment 1. Outline Slide 2. Key Market Engineering Measurements 3. Self-Printed Market Revenue Forecast 4. Revenue Analysis 5. Self-Printed Market Revenue Forecast by Segment 6. Revenue Forecast - Scanners 7. Revenue Forecast - Arrayers 8. Revenue Forecast - Hybridization Instruments 9. Revenue Forecast - Array Content 10. Forecast Assumptions 11. Understanding Growth Opportunities Software Segment 1. Outline Slide 2. Key Market Engineering Measurements 3. Executive Quote III 4. Software Market Revenue Forecast 5. Forecast Assumptions 6. Revenue Analysis 7. Understanding Growth Opportunities 8. Software Vendor Competitive Positioning Competitive Landscape 1. Outline Slide 2. Company Analysis I 3. Company Analysis II 4. Company Analysis III 5. Company Analysis IV 6. Company Analysis V 7. Company Analysis VI 8. Company Analysis VII 9. Company Analysis VIII 10. Company Analysis IX 11. Company Analysis X 12. Company Analysis XI End-User Survey 1. Outline Slide 2. Respondent Profile I 3. Respondent Profile II 4. Microarray Access 5. Analysis of Model System 6. Type of Array Used 7. Self-Printed Arrays I 8. Self-Printed Arrays II 9. Self-Printed Arrays III 10. Self-Printed Arrays IV 11. Self-Printed Arrays V 12. Commercial Arrays I 13. Commercial Arrays II 14. Commercial Arrays III 15. Commercial Arrays IV 16. Consumables I 17. Consumables II 18. Micorarray Analysis Software I 19. Micoarray Analysis Software II 20. Microarray Purchasing Decisions Decision Support Database 1. Outline Slide 2. Biochemists and Biophysicists 3. Biological and Medical Scientists 4. Biotechnology Companies I 5. Biotechnology Companies II 6. Sequencing Centers Frost & Sullivan Awards 1. Outline Slide 2. Introduction to Frost & Sullivan Awards 3. Technology Leadership Award 4. Product Innovation Award 5. Product Line Quality Frost & Sullivan 1. Outline Slide 2. Healthcare Team 3. Our Capabilities 4. Key Advantages 5. Our Consulting Clients 6. Frost & Sullivan Growth Consulting 7. Growth Consulting Process 8. Growth Consulting Deliverables 9. Growth Partnership Services 10. Growth Partnership Service Platform AbstractStandardization of Products Necessary to Drive Acceptance of Microarrays as Diagnostic ToolsManufacturers of DNA microarrays are seriously challenged to overcome laboratory-to-laboratory and platform-to-platform inconsistencies. Result variability can be linked to a variety of reasons including varying probe length and labeling protocols. Manufacturers are spending considerable time and effort in comparing their products with 'industry standards' that include quantitative polymerase chain reaction and other microarray platforms. Standardization of data is expected to be an essential part of microarrays becoming effective diagnostic tools. This research examines the World DNA Microarray Markets and discusses the competitive factors in them. It segments the market into commercial, self-printed, and software products, and breaks down total revenues by the three major geographic locations - United States, Europe, and Rest-of-World. Industry challenges, strategies, market trends and opportunities are described in detail, and have been derived through extensive interviews with market participants. Gene Expression Analyses Being Increasingly Used for Clinical Trials Gene expression products are quickly becoming integral tools for both pre-clinical and clinical research. "Gene expression analysis provides a snapshot of what is happening in a system at the molecular level," states the analyst. This information is vital to understand the workings of the system and the factors that change the system. The utility of microarray technology in the diagnostics arena is beginning to be explored. In diagnostics, microarray technology is expected to be crucial for making decisions relating to therapeutics. Microarrays have been used in research for almost a decade; however, it is their promise as a therapeutic tool that is expected to drive the market. Commercial Products to Drive Market Growth World DNA microarray revenue was $596 million in 2003 and is expected to reach $937 million by 2010, at a compound annual growth rate of 6.7 percent. Market growth is expected to be derived from the substantial gains in the commercial market and continued growth in the scanner market.
|
|
|||
|
About MarketResearch.com
|
||||